Condition
Herpes Simplex 2
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 4 (1)
Trial Status
Completed4
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04710030Phase 2Completed
Valacyclovir for Mild Cognitive Impairment
NCT05452928Phase 4Not Yet RecruitingPrimary
Aciclovir Versus Placebo for HSV-2 Meningitis
NCT03282916Phase 2Completed
Anti-viral Therapy in Alzheimer's Disease
NCT05823779Unknown
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
NCT04664127Completed
Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
NCT01681420Not ApplicableCompleted
Improving Blood Safety and HIV Testing in Brazil
Showing all 6 trials